NanoMed Pharmaceuticals Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NanoMed Pharmaceuticals Inc.
The idea of delivering drugs encased in lipids was a popular one in the early days of the biotechnology industry but manufacturing problems pushed lipid-based drug delivery from favor. NanoMed Pharmaceuticals thinks it has found a way to get lipids to fulfill their potential as delivery vehicles, shielding the drugs they contain from cellular mechanisms responsible for drug resistance. The start-up aims to leverage its know-how to treat cancers notoriously resistant to chemotherapy.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Devices for Varicose Veins, features profiles of Vascular Insights, VeinRx and Venousonics. Plus these Start-Up Across Health Care: NanoMed Pharmaceuticals, Peakadilly, Quincy Bioscience and Solidus Biosciences.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.